Proyectos

Herramientas y oportunidades para la glicociencia biomédica. BIOMAGUNE
The project aims to improve the knowledge about the role of glycans as mediators in cell adhesion, as biomarkers in cancer, as effector molecules of therapeutic antibodies and as important recognition elements in increasingly recognized host-pathogen interactions. GAIKER will study the interaction of these glycans in human blood samples and their effect on the immune system.
2018-2019
ELKARTEK Programme
Funded by the Basque Government. Department of Economic Development and Competitiveness
Subject: Biomedicine, in vitro efficacy studies, glycomedicine, blood, immune system
Leader: CIC-BIOMAGUNE

Funded by the Basque Government

Development of a product line based on Phyto-Factors through evaluation on ITS (Intelillent Testing strategy) platform for the treatment of atopic dermatitis. FITOATOPIC
The objective is to obtain a line of products with effective phyto-factors (PF) for hygiene and hydration in the treatment of atopic dermatitis that does not alter the properties of the skin or of its microbiota , without acting on the patient's immune system.
2016-2018
Retos Colaboración Programme
Funded by the Ministry of Economy and Competitiveness.
Subject: Biomedicine
Leader: FAES FARMA, S.A.

Inhalated nanomatherials mechanisms of action assessment. NANOINCELL
Physicochemical and toxicological assessment of nanomatherials derived from industrial processes.
2016-2017
OSALAN Programme
Funded by the Basque Government
Subject: Nanosystem characterization and Nanotoxicology
Leader: GAIKER-IK4

Investigación colaborativa en nuevas técnicas de imagen y biomateriales para el diagnóstico de enfermedades del sistema nervioso central. bmG 2016
New image techniques and biomatherials development for Central Nervous Systems diseases detection.
2016-2017
ELKARTEK Programme
Funded by the Department of Economic Development and Infrastructure
Subject: Biomedicine/Nanomedicine
Leader: CIC BIOMAGUNE

Development, characterization optimization and test autologous multifunctional formulations for use in regenerative medicine. AUTOCARE
Cooperative experimental platform start up that allows develop, characterize, optimize and test new autologous multifunctional formulations for use in regenerative medicine.
2016-2017
ELKARTEK Project
Funded by the Basque Government. Department of Economic Development and Competitiveness
Subject: Biomedicine
Leader: BIOTECHNOLOGY INSTITUTE I+D (BTI)

Investigación estratégica y desarrollo tecnológico en nanomedicina: aplicación a cultivo celular, diagnóstico y terapia de enfermedades infecciosas y cáncer. BIOMAGUNE 2015
Nanosystems development for the treatment of viral diseases in the respiratory system.
2015-2016
ELKARTEK Programme
Funded by the Department of Economic Development and Infrastructure
Subject: Biomedicine / Nanomedicine / Physiological barriers
Leader: CIC BIOMAGUNE

Development of new antitumour inhibitors and evaluation of combination therapies. ONCONET
The main objective of this project is to develop new anticancer drugs aimed at inhibiting the mechanisms of blood vessel formation (angiogenesis), stopping tumour growth and inducing the death of malignant cells. This research is geared towards the synthesis, "in-vitro" evaluation and selection of new molecules with anti-tumour activity against glioblastomas and other tumours with low therapeutic efficacy.
2014-2017
Retos Colaboración Programme (RTC-2014-1734-1)
Funded by the Ministry of Economy and Competitiveness
Cofunded by the European Regional Development Fund, goal: to promote the technological development, the innovation and a quality research
Subject: Human health
Leader: GENETADI BIOTECH, S.L.

NANoREG
A common regulatory approach to the regulatory testing of nanomaterials. The objective of the project is to develop a methodology to identify, evaluate and manage the risk involved in using nanomaterials and thereby prevent potential risks to the operator/consumer during the life-cycle of this type of materials.
2013
European Project VII Framework Programme
Funded by the European Commission
Subject: Human health
Leader: Netherlands Ministry of the Environment

Industry and services providing a response to the challenge of aging. ELDERBASK
This project, headed by leading research bodies in the Basque Country, is the first official step in transferring existing Basque industry value and skills with the objective of dealing with the problems generated by today's demographic tendencies, focussing on attention to the phenomenon of aging and the high rate of chronic disease existing locally and worldwide. From a gerontological point of view, the idea is to research not only "what they do", but to take a deeper look at "why they do it", identifying and monitoring the situation in order to understand what happens to them and therefore be able to do something about it beforehand and individually.
2012
ETORTEK Project
Funded by the Basque Government. Department of Industry, Trade and Tourism
Subject: eHealth
Leader: Tecnalia

DENDRIA
Development of a new integrated model to accelerate the identification and development of drug candidates in the treatment of nervous system diseases. The objective of the project is to reduce the percentage of failure of the molecules that advance during the preclinical and clinical development process, to allow early decision making in the process and therefore to help optimise resources and to obtain better and more effective medicines to deal with this group of diseases.
2011-2013
CENIT Project
Funded by the CDTI. Ministry of Science and Innovation
Subject: Human health
Leader: Noscira

Development and transferral of a non-invasive molecular diagnostics system for colon cancer in peripheral blood. CRC MARKERS
The primary target of this project is to develop a new and non-invasive molecular diagnostics system for colon cancer in peripheral blood from a routine blood extraction, to substitute other more expensive and aggressive exploratory techniques. Part of the activities in this project will involve the design of a business plan and the carrying out of activities to commercialise the results with the ultimate aim of reverting them to society. A meeting therefore took place in the same consortium between the Medical Oncology Services of several hospitals in the Osakidetza network: Cruces, Basurto and Oncologikoa through Bioef, the Dept. of Computational Sciences and Artificial Intelligence through the OTRI (Office for the Transfer of Research Results, University of the Basque Country) and Gaiker's Biomedicine Service along with its Exploitation of Results Department.
2011-2013
EKINBERRI Project. Provincial Council of Bizkaia
Funded by the Provincial Council of Bizkaia. Department of Economic Promotion
Subject: Molecular markers, diagnostics, cancer
Leader: GAIKER

Open health platform in biopharmaceutical experimentation. PLASMA
To develop an infrastructure to support all phases in the research and development of new biomarkers and drugs. The idea is to provide an experimentation platform, open and accessible to the science and research community in the field of drug development. This will provide a cross-cutting research basis, the validity of which as an approach and effective tool can be proven.
This project aims to establish the basis for the first of the clinical experimentation phases, and to provide the elements necessary for more effective development of those that follow. The preclinical phase represents more than 27% of total investment in the R&D of a pharmaceutical product.
At PLASMA the intention is to introduce strategies leading to drug discoveries by means of the shared and open use of available information. To achieve this, one essential task is the design and implementation of a platform to support the research and development phases of a drug and the later stages of its associated clinical experimentation.
2011-2012
EMAITEK Project
Funded by the Basque Government. Department of Industry, Trade and Tourism
Subject: eHealth
Leader: IK4

Development of an in vitro model of the haematoencephalic barrier. SYNTHEBAR
Development and evaluation of a cell model useful for the evaluation of absorption in the haematoencephalic barrier.
2010-2012
EMAITEK Project
Funded by the Basque Government
Subject: cell model development
Leader: GAIKER

Phosphoproteomics and predictive toxicology of an immortal human hepatocyte cell line. PREDICTOX
Study of the presence of new phosphorylated early toxicology markers in a new immortal human hepatocyte cell line to be used in pharmacological tests
2009-2011
ETORTEK Project
Funded by the Basque Government
Subject: Toxicogenomics
Leader: CIC BioGUNE